|

Safety and Efficacy of Endoscopic Ultrasound-Guided Portal Pressure Gradient Measurement

RECRUITINGN/ASponsored by Methodist Health System
Actively Recruiting
PhaseN/A
SponsorMethodist Health System
Started2020-12-23
Est. completion2025-01-01
Eligibility
Age18 Years – 85 Years
Healthy vol.Accepted
Locations1 site
View on ClinicalTrials.gov →

NCT06336850

Summary

The purpose of this study is to evaluate the efficacy, safety, and adequacy of Endoscopic Ultrasound (EUS) Portal Pressure Gradient Measurement (PPGM) in patients undergoing EUS-guided liver biopsies.

Eligibility

Age: 18 Years – 85 YearsHealthy volunteers accepted
INCLUSION CRITERIA

* Age 18 years or older
* Patient who has been referred for EUS procedure and direct PPG measurement and -undergoing EUS-guided liver biopsy
* History of liver disease or suspected cirrhosis and considered for PPGM

EXCLUSION CRITERIA

* Patient is less than 18 or greater than 85 years of age
* Patient is pregnant, breast-feeding, or planning to become pregnant during the course of the study
* Patient is unwilling or unable to sign and date the informed consent
* Patient for whom endoscopic procedures are contraindicated.

Conditions2

Liver DiseaseLiver Diseases

Locations1 site

Methodist Dallas Medical Center
Dallas, Texas, 75203
Prashant Kedia, MD

Browse More Trials

Liver Disease trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.